Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 649 of 1,261
  1. US 9567609

    Compositions for linking DNA-binding domains and cleavage domains

    Sangamo Biosciences, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  2. US 9568473

    Methods for detecting Ehrlichia infection

    The Board of Regents of the University of Texas System · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  3. US 9567588

    Modulation of androgen receptor expression

    Ionis Pharmaceuticals, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  4. US 9567587

    Antisense modulation of GCCR expression

    Ionis Pharmaceuticals, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  5. US 9567584

    Oligonucleotide—containing pharmacological compositions and their use

    Lakewood Amedex, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  6. US 9567572

    Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  7. US 9567573

    Genome editing of a Rosa locus using nucleases

    Sangamo Biosciences, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  8. US 9567564

    Progenitor cells from Wharton's jelly of human umbilical cord

    Tissue Regeneration Therapeutics Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  9. US 9567393

    Antibody based reagent that specifically recognizes toxic oligomeric form of beta-amyloid

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  10. US 9567348

    Substituted pyrazolo[1,5-a]pyrimidines as Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  11. US 9567439

    Sulfur composites and polymeric materials from elemental sulfur

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  12. US 9567387

    T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  13. US 9567300

    Hexahydropentaleno derivatives, preparation method and use in medicine thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  14. US 9566355

    Bacteria-targeted magnetic resonance contrast agents

    Northwestern University · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  15. US 9566352

    Methods and compositions for inhibiting viral entry into cells

    Sangamo Biosciences, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  16. US 9566340

    Monomers and oligonucleotides comprising cycloaddition adduct(s)

    Alnylam Pharmaceuticals, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  17. US 9567296

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  18. US 9566320

    Mucin-associated surface protein as vaccine against Chagas disease

    The Board of Regents of the University of Texas System · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  19. US 9566329

    Live, attenuated rubella vector to express vaccine antigens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  20. US 9566314

    Extracellular vesicles comprising recombinant lysosomal transmembrane protein

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  21. US 9566294

    Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis

    Northwest Biotherapeutics, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  22. US 9566283

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  23. US 9566271

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  24. US 9566278

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.